Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lisata Therapeutics (LSTA) Interest & Investment Income (2023 - 2025)

Lisata Therapeutics filings provide 3 years of Interest & Investment Income readings, the most recent being $141000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Interest & Investment Income fell 59.71% year-over-year to $141000.0, compared with a TTM value of $806000.0 through Dec 2025, down 57.2%, and an annual FY2025 reading of $806000.0, down 57.2% over the prior year.
  • Interest & Investment Income hit $141000.0 in Q4 2025 for Lisata Therapeutics, down from $183000.0 in the prior quarter.
  • The five-year high for Interest & Investment Income was $714000.0 in Q3 2023, with the low at $141000.0 in Q4 2025.
  • Median Interest & Investment Income over the past 3 years was $472000.0 (2024), compared with a mean of $451000.0.
  • The sharpest move saw Interest & Investment Income fell 12.09% in 2024, then plummeted 59.71% in 2025.
  • Year by year, Interest & Investment Income stood at $671000.0 in 2023, then plummeted by 47.84% to $350000.0 in 2024, then crashed by 59.71% to $141000.0 in 2025.
  • According to Business Quant data, Interest & Investment Income over the past three periods came in at $141000.0, $183000.0, and $216000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.